Endocrinologist and a fair chunk of the nation’s primary care physicians are enlisting e-prescribing programs to treat both Medicare and non-Medicare patients, and the treatment tallies are only expected to rise in the coming year, a Decision Resources report posits.
According to the survey findings, doctors are e-prescribing with 76 percent of Medicare patients and 79 percent of non-Medicare patients. Moreover, electronic medical record use has allowed for 60 percent of the physicians surveyed to access patient formularies with record ease, allowing for them to heed more attention to patient costs.
"The vast majority of physicians say their electronic health record [EHR] systems only have patient information from their own physician group, meaning they have incomplete information on their patients -- this lack of shared information represents a shortcoming of current EHR adoption and prevents improved patient management," said Roy Moore, Decision Resources product manager, in a prepared statement. "The ability of EHRs to aggregate data and allow for population health management — an underutilized feature today — will allow marketers of branded therapies to demonstrate the superiority of their products versus other competitors and generics. Physician and MCO desires to reduce costs and hospitalizations should make them receptive to clinical data showing therapies' effectiveness along these metrics."
Other survey results touched upon DPP-IV inhibitor costs alongside MCO observation of physician prescribing habits affected by e-prescribing solutions:
All information and data courtesy of Decision Resources. Presentation by PhysBizTech.
A total of 70 PCPs, 70 endocrinologists and 25 MCO pharmacy directors were queried as a means to help the industry better understand “the impact of these healthcare technology trends on physician behavior” and therein make it so “drug marketers can plan to either withstand the headwinds emerging from this movement or take advantage of dynamics that favor their therapies,” the survey declared.
Find the full report, titled “E-Prescribing and Electronic Health Records: Impact of Technology on Prescribing for Hypertension and Diabetes,” here.